Diagnosis and treatment of glucocorticoid-induced osteoporosis.
Glucocorticoids are a mainstay in the treatment of many diseases, including pulmonary and rheumatologic disorders. Unfortunately, as many as 90% of long-term glucocorticoid recipients lose a significant amount of bone and incur an increased risk of fractures. This paper reviews the pathophysiology, diagnosis, and treatment of glucocorticoid-induced osteoporosis.
Zaqqa
D
D
Department of Internal Medicine, Ohio State University, USA.
Jackson
R D
RD
D019468:Disease Management; D050723:Fractures, Bone / Q000139:chemically induced; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D012307:Risk Factors
D005938:Glucocorticoids